Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » a16z begins investing in DeSci with AminoChain, leads $5M seed round
    Investments

    a16z begins investing in DeSci with AminoChain, leads $5M seed round

    userBy userSeptember 25, 2024No Comments2 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    Key Takeaways

    • AminoChain is developing a decentralized biobank and Layer 2 network for secure medical data sharing.
    • The Specimen Center will be AminoChain’s first application, facilitating interoperable biobank networks.

    Share this article







    Andreessen Horowitz (a16z) has made its first investment in a decentralized science (DeSci) project, backing AminoChain with $5M in a seed funding round.

    In 1951, Henrietta Lacks’ cells were taken without her knowledge or consent. Her cells, known now as “HeLa” cells, went on to become one of the most important tools in modern medicine, leading to breakthroughs in healthcare from the polio vaccine to cancer treatments. For 72… pic.twitter.com/01tZme6gLL

    — AriannaSimpson.eth (@AriannaSimpson) September 25, 2024

    The funding, led by a16z, will support AminoChain’s development of a decentralized biobank and Layer 2 network. The project aims to improve ownership, transparency, and consent in medical data collection, utilizing blockchain technology to allow enterprise medical institutions to share data securely and while maintaining patient privacy.

    AminoChain’s platform includes a proprietary software called “Amino Node,” which integrates with medical institutions’ tech stacks. The software ensures that while the data remains under self-custody on institutional servers, it is harmonized into a standardized format for interoperable collaboration. This system allows developers to build patient-centric applications and source data from various institutions.

    The project’s first product will be the Specimen Center, a peer-to-peer marketplace for bio-samples, enabling biobanks to provide researchers access to their collections and track biosample provenance across networks. AminoChain previously raised $2M in pre-seed funding, bringing its total capital raised to $7M.

    The investment is notable for its impact on decentralized science, a growing movement to make scientific research more open and collaborative by using blockchain. For the crypto industry, it represents another step toward applying decentralized technology to traditionally centralized sectors like healthcare, potentially reshaping medical data sharing and research collaboration.

    Decentralized science (DeSci) seeks to reform scientific research by utilizing blockchain, Web3 principles, addressing funding, publishing, and collaborative issues, and integrating NFT-based IP management and decentralized data storage. Key projects like VitaDAO, ResearchHub, Molecule Protocol, and AthenaDAO are leading the DeSci movement, showcasing their roles from funding to data management through blockchain applications.

    Share this article











    Source link

    Share this:

    • Click to share on Facebook (Opens in new window) Facebook
    • Click to share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticlePrices have hit an all-time high
    Next Article Meta to buy 3.9 million carbon credits from controversial tree plantations
    user
    • Website

    Related Posts

    Australia’s investment in large-scale wind and solar hits six-year peak | Energy

    February 13, 2025

    Investing in fixed-income ETFs as market weighs Fed forecasts

    February 12, 2025

    Citigroup launches new preferred stock series By Investing.com

    February 12, 2025
    Add A Comment

    Leave a ReplyCancel reply

    © 2025 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d